Organization Overview
Alternative names
albumin (Human) (Plasbumin) (1 trial)
asparaginase (elspar) (4 trials)
atazanavir (reyataz) (3 trials)
atorvastatin (lipitor) (2 trials)
autologous dendritic cells (1 trial)
bevacizumab (avastin) (2 trials)
capecitabine (xeloda) (1 trial)
cyclophosphamide (cytoxan) (8 trials)
cytarabine (cytosar-u) (7 trials)
doxorubicin (Doxil) (4 trials)
efavirenz (sustiva) (4 trials)
emtricitabine (emtriva) (2 trials)
etoposide (vepesid) (3 trials)
fluorouracil (efudex) (4 trials)
fluticasone (cutivate) (1 trial)
formoterol (foradil) (1 trial)
ibandronate (boniva) (1 trial)
interferon alpha-2b (Intron-A) (2 trials)
irinotecan (Camptosar) (3 trials)
lopinavir (Kaletra) (6 trials)
maraviroc (selzentry) (2 trials)
mercaptopurine (purinethol) (3 trials)
methylprednisolone (medrol) (3 trials)
mitoxantrone (novantrone) (2 trials)
nevirapine (viramune) (4 trials)
oxaliplatin (eloxatin) (5 trials)
panitumumab (vectibix) (2 trials)
phenytoin (mesantoin) (1 trial)
prednisone (meticorten) (8 trials)
raltegravir (isentress) (6 trials)
cabazitaxel (jevtana kit) (1 trial)
carboplatin (paraplatin) (3 trials)
cisplatin (platinol) (3 trials)
etravirine (intelence) (1 trial)
gemcitabine (gemzar) (4 trials)
hydroxychloroquine (plaquenil) (1 trial)
idursulfase (elaprase) (1 trial)
liposomed heat-inactivated mycobacterium tuberculosis bacilli (2 trials)
acetylsalicylic acid (aspirin) (1 trial)
aflibercept (zaltrap) (1 trial)
alprostadil (prostin) (1 trial)
alteplase (Activase) (1 trial)
belinostat (beleodaq) (1 trial)
bendamustine (treanda) (3 trials)
bone marrow derived mesenchymal stem cells (1 trial)
cabozantinib (cometriq) (1 trial)
deferoxamine (desferal) (1 trial)
docetaxel (taxotere) (2 trials)
erlotinib (tarceva) (4 trials)
escitalopram (lexapro) (1 trial)
everolimus (zortress) (1 trial)
evolocumab (repatha) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 4)
Adenocarcinoma (Phase 3)
Aggression (Phase 2)
Asthma (Phase 4)
Brain Diseases (Phase 4)
Burkitt Lymphoma (Phase 2)
Carcinoma (Phase 4)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Small Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 4)
Cardiac Output, Low (Phase 3)
Cerebral Infarction (Phase 3)
Colonic Diseases (Phase 3)
Colonic Neoplasms (Phase 4)
Colorectal Neoplasms (Phase 2)
Communicable Diseases (Phase 4)
Conjunctivitis (Phase 2)
Dementia (Phase 3)
Depression (Phase 2)
Depressive Disorder (Phase 2)
Depressive Disorder, Major (Phase 2)
Dermatitis (Phase 2)
Dermatitis, Atopic (Phase 2)
Diabetes Mellitus (Phase 3)
Eczema (Phase 2)
Fibromyalgia (Phase 3)
Fibrosis (Phase 4)
Glioblastoma (Phase 2)
Glomerulonephritis (Phase 2)
Glomerulonephritis, IGA (Phase 2)
Glomerulonephritis, Membranous (Phase 3)
Head and Neck Neoplasms (Phase 2)
Heart Failure (Phase 4)
Hepatic Encephalopathy (Phase 4)
Hepatitis (Phase 2)
Hepatitis A (Phase 2)
Hepatitis, Alcoholic (Phase 2)
Hepatitis C (Phase 4)
Hepatitis C, Chronic (Phase 2)
Hepatoblastoma (Phase 3)
HIV Infections (Phase 4)
Hodgkin Disease (Phase 3)
Infarction (Phase 3)
Infarction, Middle Cerebral Artery (Phase 2)
Infections (Phase 4)
Ischemia (Phase 2)
Kidney Diseases (Phase 3)
Latent Tuberculosis (Phase 2)
Leukemia (Phase 4)
Leukemia, Lymphoid (Phase 4)
Leukemia, Myeloid (Phase 3)
Liver Cirrhosis (Phase 4)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 4)
Lymphoma, B-Cell (Phase 4)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 4)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Meningitis (Phase 4)
Meningitis, Pneumococcal (Phase 4)
Metabolic Syndrome (Phase 2)
Mucopolysaccharidoses (Phase 3)
Mucopolysaccharidosis II (Phase 3)
Multiple Sclerosis (Phase 4)
Multiple Sclerosis, Chronic Progressive (Phase 1)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myocardial Infarction (Phase 1)
Neoplasm Metastasis (Phase 4)
Neoplasms (Phase 3)
Neoplasms, Second Primary (Phase 4)
Osteoporosis (Phase 4)
Peritoneal Diseases (Phase 2)
Philadelphia Chromosome (Phase 4)
Prostatic Neoplasms (Phase 3)
Rectal Neoplasms (Phase 2)
Recurrence (Phase 4)
Sclerosis (Phase 4)
Seizures (Phase 4)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Status Epilepticus (Phase 3)
Stroke (Phase 3)
Syndrome (Phase 3)
Thrombosis (Phase 3)
Tuberculosis (Phase 3)
Tuberculosis, Multidrug-Resistant (Phase 2)
Tuberculosis, Pulmonary (Phase 2)
Urinary Bladder Neoplasms (Phase 1)
Viremia (Phase 3)
Weight Loss (Phase 3)
